191 related articles for article (PubMed ID: 15184053)
1. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
Lodygin D; Diebold J; Hermeking H
Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
4. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
Lodygin D; Hermeking H
Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
Ide M; Nakajima T; Asao T; Kuwano H
Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
[TBL] [Abstract][Full Text] [Related]
7. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
Kang J; Bu J; Hao Y; Chen F
Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of 14-3-3sigma in cancer.
Lodygin D; Hermeking H
Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
[TBL] [Abstract][Full Text] [Related]
9. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
[TBL] [Abstract][Full Text] [Related]
10. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Yoo J; Lee YJ
Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
[TBL] [Abstract][Full Text] [Related]
11. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
12. Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells.
Ling MT; Kwok WK; Fung MK; Xianghong W; Wong YC
Carcinogenesis; 2006 Feb; 27(2):205-15. PubMed ID: 16123120
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
15. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
[TBL] [Abstract][Full Text] [Related]
16. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells.
Hod Y
J Cell Biochem; 2004 Aug; 92(6):1221-33. PubMed ID: 15258905
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
[TBL] [Abstract][Full Text] [Related]
18. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
Zhang X; Jin TG; Yang H; DeWolf WC; Khosravi-Far R; Olumi AF
Cancer Res; 2004 Oct; 64(19):7086-91. PubMed ID: 15466204
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter-Edouart AS; Lemoine J; Le Bourhis X; Louis H; Boilly B; Nurcombe V; Révillion F; Peyrat JP; Hondermarck H
Cancer Res; 2001 Jan; 61(1):76-80. PubMed ID: 11196201
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
